Crossmark

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

Crossref DOI link: https://doi.org/10.1186/s13195-018-0362-2

Published Online: 2018-03-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baldeiras, Inês http://orcid.org/0000-0002-8106-7308
Santana, Isabel

Leitão, Maria João

Gens, Helena

Pascoal, Rui

Tábuas-Pereira, Miguel

Beato-Coelho, José

Duro, Diana

Almeida, Maria Rosário

Oliveira, Catarina Resende
Funding

Funding for this research was provided by:

Fundação para a Ciência e a Tecnologia (PD/BD/135108/2017)

Fundação para a Ciência e a Tecnologia (SFRH/BD/52289/2013)
License Information

Text and Data Mining valid from 2018-03-20
More Information

Article History

Received: 15 December 2017

Accepted: 25 February 2018

First Online: 20 March 2018

Ethics approval and consent to participate

: This study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and was approved by the Ethics Board of Coimbra University Hospital. All subjects or responsible caregivers, whichever appropriate, gave their informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below